Fennec Pharmaceuticals (FENC) Gross Profit (2023 - 2025)

Fennec Pharmaceuticals (FENC) has 3 years of Gross Profit data on file, last reported at $7.7 million in Q4 2025.

• For the quarter ending Q4 2025, Gross Profit rose 92.69% year-over-year to $7.7 million; the trailing twelve-month figure through Dec 2025 stood at $32.0 million (down 13.59% YoY), and the FY2025 full-year result was $26.0 million, down 10.6% from the prior year.
• Gross Profit for Q4 2025 stood at $7.7 million, up from $7.3 million in the prior quarter.
• Across five years, Gross Profit topped out at $24.8 million in Q1 2024 and bottomed at $1.6 million in Q1 2023.
• The 3-year median for Gross Profit is $6.7 million (2023), against an average of $7.4 million.
• The widest annual swing landed in 2024, when Gross Profit surged 1469.34%; it then plunged 66.25% in 2025.
• A 3-year view of Gross Profit shows it stood at $9.0 million in 2023, then tumbled by 56.01% to $4.0 million in 2024, then soared by 92.69% to $7.7 million in 2025.
• The last three Gross Profit figures came in at $7.7 million (Q4 2025), $7.3 million (Q3 2025), and $8.7 million (Q2 2025), per Business Quant data.

Peer Comparison